| Year |
Citation |
Score |
| 2021 |
Olszewski K, Barsotti A, Feng XJ, Momcilovic M, Liu KG, Kim JI, Morris K, Lamarque C, Gaffney J, Yu X, Patel JP, Rabinowitz JD, Shackelford DB, Poyurovsky MV. Inhibition of glucose transport synergizes with chemical or genetic disruption of mitochondrial metabolism and suppresses TCA cycle-deficient tumors. Cell Chemical Biology. PMID 34715056 DOI: 10.1016/j.chembiol.2021.10.007 |
0.538 |
|
| 2020 |
Liu KG, Kim JI, Olszewski K, Barsotti AM, Morris K, Lamarque C, Yu X, Gaffney J, Feng XJ, Patel J, Poyurovsky M. Discovery and Optimization of Glucose Uptake Inhibitors. Journal of Medicinal Chemistry. PMID 32282207 DOI: 10.1021/acs.jmedchem.9b02153 |
0.503 |
|
| 2018 |
Moon SH, Huang CH, Houlihan SL, Regunath K, Freed-Pastor WA, Morris JP, Tschaharganeh DF, Kastenhuber ER, Barsotti AM, Culp-Hill R, Xue W, Ho YJ, Baslan T, Li X, Mayle A, et al. p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression. Cell. PMID 30580964 DOI: 10.1016/J.Cell.2018.11.011 |
0.691 |
|
| 2012 |
Singer S, Zhao R, Barsotti AM, Ouwehand A, Fazollahi M, Coutavas E, Breuhahn K, Neumann O, Longerich T, Pusterla T, Powers MA, Giles KM, Leedman PJ, Hess J, Grunwald D, et al. Nuclear pore component Nup98 is a potential tumor suppressor and regulates posttranscriptional expression of select p53 target genes. Molecular Cell. 48: 799-810. PMID 23102701 DOI: 10.1016/J.Molcel.2012.09.020 |
0.684 |
|
| 2012 |
Freed-Pastor WA, Mizuno H, Zhao X, Langerød A, Moon SH, Rodriguez-Barrueco R, Barsotti A, Chicas A, Li W, Polotskaia A, Bissell MJ, Osborne TF, Tian B, Lowe SW, Silva JM, et al. Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Cell. 148: 244-58. PMID 22265415 DOI: 10.1016/J.Cell.2011.12.017 |
0.676 |
|
| 2012 |
Barsotti AM, Beckerman R, Laptenko O, Huppi K, Caplen NJ, Prives C. p53-Dependent induction of PVT1 and miR-1204. The Journal of Biological Chemistry. 287: 2509-19. PMID 22110125 DOI: 10.1074/Jbc.M111.322875 |
0.656 |
|
| 2010 |
Barsotti AM, Prives C. Noncoding RNAs: the missing "linc" in p53-mediated repression. Cell. 142: 358-60. PMID 20691894 DOI: 10.1016/J.Cell.2010.07.029 |
0.634 |
|
| 2009 |
Barsotti AM, Prives C. Pro-proliferative FoxM1 is a target of p53-mediated repression. Oncogene. 28: 4295-305. PMID 19749794 DOI: 10.1038/Onc.2009.282 |
0.688 |
|
| 2008 |
Baptiste-Okoh N, Barsotti AM, Prives C. Caspase 2 is both required for p53-mediated apoptosis and downregulated by p53 in a p21-dependent manner. Cell Cycle (Georgetown, Tex.). 7: 1133-8. PMID 18418048 DOI: 10.4161/Cc.7.9.5805 |
0.657 |
|
| 2008 |
Baptiste-Okoh N, Barsotti AM, Prives C. A role for caspase 2 and PIDD in the process of p53-mediated apoptosis. Proceedings of the National Academy of Sciences of the United States of America. 105: 1937-42. PMID 18238895 DOI: 10.1073/Pnas.0711800105 |
0.639 |
|
| Show low-probability matches. |